Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis

Danby SG , Cork MJ. A new understanding of atopic dermatitis: the role of epidermal barrier dysfunction and subclinical inflammation. J Clin Dermatol 2010;1:1-33.

Kalinin A. Assembly of the cornified envelope. J Cell Sci 2001;114:3069.

Elias PM. The skin barrier as an innate immune element. Semin Immunopathol 2007;29:29-3.

Cork J , Danby SG , Vasilopolous Y . Epidermal barrier dysfunction in atopic dermatitis. Soc Investig Dermatol 2009. doi:10.1038/jid.

Epstein H. Skincare products. In: Paye M , Barel A , Maibach H , editors. Handbook of cosmetic science and technology. 2nd ed. Boca Raton: CRC Press; 2006. p. 427-39.

Kligman AM. The biology of the stratum corneum. In: Montagna W , Lobitz WC , editors. The epidermis. New York: Academic Press; 1964. p. 387-433.

Mao-Qiang M , Feingold KR , Thornfeld CR , Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 1996;106:106-1096.

Finegold KR. Cholesterol synthesis is required for cutaneous barrier function in mice. Clin Invest 1990;86:18738.

Harding CR. The stratum corneum structure and function in health and disease. Dermatol Ther 2004;17:6.

Brown SJ. Atopic eczema and the filaggrin story. Semin Cutan Med Surg 2008;27:27-128.

Bierber T. Mechanisms of disease: atopic dermatitis. N Engl J Med 2008;358:358-1483.

Mancini AJ. Barrier repair creams: another therapeutic option for the acute and long-term management of atopic dermatitis. Clinical Insights. Available at: http://bmctoday.net/practicaldermatologypeds/2010/08/insert/article.asp?f=barrier-repair-creams-another-therapeutic-option-for-the-acute-and-long-term-management-of-atopic-dermatitis (accessed on January 30, 2012).

Elias PM , Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 2009;9:9-265.

Bos JD , Brenninkmeijer EEA , Schram ME . Atopic eczema or atopiform dermatitis. Exp Dermatol 2010. doi:10.1111/j.1600–0625.2009.01024.x.

Krakowski A , Eichenfield LE Atopic dermatitis basics: three common myths debunked. Pract Dermatol Pediatr 2010; May/June :39-42.

Rhein L. Surfactants in cosmetics. In-vitro interactions: biochemical and biophysical effects of surfactants on skin. New York: Surfa Science Series; 1997.

Sugarman JL. The epidermal barrier in atopic dermatitis. Semin Cutan Med Surg 2008;28:28-108.

Kim M , Jung M , Hong SP. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp Dermatol 2009;19:19-501.

Bikowski J. Case studies assessing a new skin barier repair cream for the treatment of atopic dermatitis. J Drugs Dermatol 2009;8;1037–41.

Sugarman JL , Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe atopic dermatitis. J Drugs Dermatol 2009;8:8-1106.

Kircik L , Del Rosso J. EPIC Study. Evaluating clinical use of a ceramide-dominant, physiologic lipid-based topical emulsion for atopic dermatitis. J Clin Aesthet Dermatol 2011;4:4-34.

Abramovits W , Boguniewicz M. A multicenter, randomized, vehicle-controlled clinical study to examine the safety and efficacy of MAS063DP in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol 2006;5:5-236.

Patrizi A. A double blind randomized vehicle-controlled study to evaluate the efficacy and safety of MAS063DP (Atopiclair) in the management of AD in the pediatric population. Pediatr Allergy Immunol 2008;19:19-619.

Elias PM. Barrier repair therapy for atopic dermatitis: corrective lipid biochemical therapy. Expert Rev Dermatol 2008;3:3-441.

Belloni G , Pinelli S , Veraldi S. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis. Eur J Dermatol 2005;15:15-31.

Emer JJ , Frankel A , Sohn A , Lebwohl M. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis. J Drugs Dermatol 2011;10:10-735.

Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis 2008;81:81-87.

Wollenberg A , Reitamo S , Atzori F . Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008;63:63-742.